menu
    • menu

    Company profile for Anji Pharmaceutical

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anji Pharma is a clinical-stage biotech company with operations in the U.S., Beijing, and Shanghai. Our deep science expertise and our innate problem-solving enable Anji to bring medicines to patients around the world – quickly and safely.At Anji, “getting it done” is our north star. We prioritize high-value, late-stage therapies with human evidence that it works. It’s an approach that brings higher clinical success ra...
    Anji Pharma is a clinical-stage biotech company with operations in the U.S., Beijing, and Shanghai. Our deep science expertise and our innate problem-solving enable Anji to bring medicines to patients around the world – quickly and safely.At Anji, “getting it done” is our north star. We prioritize high-value, late-stage therapies with human evidence that it works. It’s an approach that brings higher clinical success rates, lower development costs, and long-term value for our partners. No red tape, no hype; just a steadfast focus on results.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anji PharmaceuticalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main Street ,Cambridge, MA 02142, USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://anjipharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anji-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AnjiPharmaUS

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anji Pharma and Population Health Partners Enter into Strategic Collaboration
    Anji Pharma and Population Health Partners Enter into Strategic Collaboration

    19 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221019005205/en

    BUSINESSWIRE
    19 Oct 2022
    Share Share
    Anji Pharma Provides Update on ANJ900 Pivotal Program
    Anji Pharma Provides Update on ANJ900 Pivotal Program

    02 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220602005253/en

    BUSINESSWIRE
    02 Jun 2022
    Share Share
    Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat
    Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat

    18 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220518005100/en

    BUSINESSWIRE
    18 May 2022
    Share Share
    Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry
    Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry

    05 Oct 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/eli-lilly-backed-ipinovyx-bio-emerges-10m-for-2023-clinical-entry

    Kyle LaHucik FIERCEBIOTECH
    05 Oct 2021
    Share Share
    Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset
    Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset

    29 Sep 2021

    // K. LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/anji-pharma-secures-70m-series-b-for-phase-3-diabetes-asset-mid-stage-constipation

    K. LaHucik FIERCEBIOTECH
    29 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search